http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103547570-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-81
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4412
filingDate 2012-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e592ce9f42fed00375d9e5ee99867d4a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_acfca9ae313fd14ba9fece769b33e8d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4742d5703ad4924cd61a49714f558d5a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4e5d1f4bf9f923c081bc1e3121d8fb6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c3bc57a789c386d4828879473081329
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_303a399d2eec7fc67d524b3c6cfb6083
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f94f11b9ed7ec3b7f38b2b3c6203c545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2232694a6ed301dc6e69e36d71dc059f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5916ebda7388f121b418e5086249da9c
publicationDate 2014-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103547570-A
titleOfInvention Pyridinecarboxamido-propionic acid derivatives useful as glucagon receptor antagonists
abstract The present invention relates to pyridinecarboxamido-propionic acid derivatives, pharmaceutical compositions containing said derivatives and their usefulness in the treatment and/or prevention of disorders and conditions ameliorated by antagonism of one or more glucagon receptors For use in , disorders and conditions including, for example, metabolic diseases such as type II diabetes and obesity.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110023309-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110023309-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109923109-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109923109-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110072858-A
priorityDate 2011-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007111864-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004056763-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03048109-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID89236277
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465391767
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421805736
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465644983
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466093812
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163637433
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420775121
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86766110
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421796226
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71060070
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163725520
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421796002
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9964725
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421795957
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421805737
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71059980
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467563961
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467427719
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465995629
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466653805
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86674293
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164138589
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465265493
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163900008

Total number of triples: 58.